Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson's and Alzheimer's
New Patent Covers Over 150 Novel CompoundsMELBOURNE, Australia and SAN FRANCISCO, Aug. 23, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying...
Source: marketscreener.com